publication venue for
- The Delta Delta: Gaps in Screening and Patient Assessment for Hepatitis D Virus Infection. 2022
- Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts. 2022
- Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross-sectional study.. 28. 2020
- Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection.. 26. 2018
- Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.. 25. 2018
- Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan.. 25. 2018
- Strategies to manage hepatitis C virus infection disease burden-Volume 4.. 24 Suppl 2. 2017
- The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4.. 24 Suppl 2. 2017
- Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts.. 24. 2017
- Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.. 24. 2017
- Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention.. 24. 2017
- Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings.. 22. 2014
- Hepatitis C virus treatment and survival in patients with hepatitis C and human immunodeficiency virus co-infection and baseline anaemia.. 20. 2013
- New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India.. 20. 2012
- Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.. 19. 2012
- Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations.. 19. 2011
- Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.. 19. 2010
- The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort.. 18. 2010
- Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection.. 17. 2009
- Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma.. 17. 2009
- Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.. 16. 2009
- Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.. 15. 2008
- Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.. 15. 2007
- Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans.. 14. 2007
- Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis.. 14. 2007
- Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.. 12. 2005
- Reasons for non-treatment of hepatitis C in veterans in care.. 12. 2005
- Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins.. 3. 1996
- Quantifying current hepatitis C virus incidence in Egypt.. 20. 2013
- Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C. 2008
- Evaluating the evidence from clinical trials in chronic hepatitis C. 2006